In early 2009, UCLA launched the Institute of Urologic Oncology, a first-of-its-kind, patient-centered institute dedicated to developing leading-edge therapies for the treatment of urological cancers, including bladder cancer.
The Institute's mission is to develop new breakthroughs in cancer care, pioneer experimental treatment options and conduct ongoing research into the causes and potential cures of urologic malignancies, offering new hope for patients from all walks of life.
A division of the UCLA David Geffen School of Medicine’s Department of Urology, the Institute is primarily affiliated with two facilities, the Ronald Reagan UCLA Medical Center and Santa Monica UCLA Medical Center and Orthopaedic Hospital. The Institute also works closely with medical specialists and research scientists at UCLA's renowned Jonsson Comprehensive Cancer Center to deliver world-class care and develop new treatments for bladder cancer patients.
UCLA has also opened several community practices to allow easier access to comprehensive bladder cancer care services, and which provide both inpatient and outpatient facilities. Additional specialized urologic oncology services may also be provided through the Clark-Morrison Children's Urological Center at UCLA and the UCLA Center for Male Urology.
Clinical trials are carefully controlled research studies in which cancer patients help doctors and scientists find ways to improve health and cancer care, and to make sure the treatments are safe and effective. Each study is designed to address and answer specific scientific questions and to find better ways to prevent, diagnose or treat cancer. A clinical trial is one of the final stages resulting from the research conducted during intensive and lengthy laboratory studies.
If you are interested in finding out more about these studies, visit our Clinical Trials Guide for general information and a listing of currently open clinical trials.
For more information on bladder cancer treatment services at UCLA, visit the following related website: